Growth Story Still Intact For AbCellera Biologics Inc (ABCL)
AbCellera Biologics Inc (ABCL) concluded trading on Wednesday at a closing price of $2.39, with 4.39 million shares of worth about $10.48 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -6.64% during that period and on March 05, 2025 the price saw a […]
Assessing Whether AbCellera Biologics Inc (NASDAQ: ABCL) Is Over- Or Undervalued
AbCellera Biologics Inc (ABCL) concluded trading on Thursday at a closing price of $2.92, with 5.36 million shares of worth about $15.64 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 8.55% during that period and on February 27, 2025 the price remained unchanged. […]
AbCellera Biologics Inc (NASDAQ: ABCL): Analyst View Points To Future Growth
AbCellera Biologics Inc (ABCL) concluded trading on Thursday at a closing price of $3.14, with 4.24 million shares of worth about $13.3 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 17.60% during that period and on February 13, 2025 the price saw a […]
Analysts Update Their Price Forecasts For AbCellera Biologics Inc (ABCL)
AbCellera Biologics Inc (ABCL) concluded trading on Wednesday at a closing price of $3.20, with 4.08 million shares of worth about $13.05 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -0.93% during that period and on January 29, 2025 the price saw a […]
Set Your Sights On AbCellera Biologics Inc (NASDAQ: ABCL)’S Upside Potential
AbCellera Biologics Inc (ABCL) concluded trading on Wednesday at a closing price of $3.53, with 11.02 million shares of worth about $38.92 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 17.28% during that period and on January 22, 2025 the price saw a […]
Growing Through Challenges? – AbCellera Biologics Inc (ABCL)
Currently, there are 295.16M common shares owned by the public and among those 221.93M shares have been available to trade. The company’s stock has a 5-day price change of -16.31% and 6.95% over the past three months. ABCL shares are trading -5.46% year to date (YTD), with the 12-month market performance down to -49.17% lower. […]
Analysts Update Their Price Forecasts For AbCellera Biologics Inc (ABCL)
AbCellera Biologics Inc (ABCL) concluded trading on Wednesday at a closing price of $3.03, with 3.6 million shares of worth about $10.92 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 8.21% during that period and on January 08, 2025 the price saw a […]
